Literature DB >> 15026626

No hypersensitive estrogen receptor-alpha mutation (K303R) in Japanese breast carcinomas.

Eriko Tokunaga1, Yasue Kimura, Yoshihiko Maehara.   

Abstract

Recently, a common somatic mutation, A-to-G transition at nucleotide 908, in the estrogen receptor-alpha (ERalpha) gene has been reported. This mutation causes an amino acid change in the ER hinge domain (lysine 303 to arginine, K303R) and confers an increased sensitivity to estrogen and an increased cellular proliferative potential. This mutation has been observed more frequently in breast cancers than in premalignant lesions. According to the previously published reports, the mutation was found in 62% of invasive breast cancers, 85% of the node-positive tumors, and 30% of proliferative breast hyperplasias in the study of US women. The purpose of our study was to investigate whether or not this mutation is present in breast cancers found in Japanese women. We performed mutation analysis using the genomic PCR and direct sequencing in 101 cases of breast cancer and eight cases of benign breast lesions. No K303R mutation was found in the ERalpha gene in these breast lesions obtained from Japanese patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026626     DOI: 10.1023/B:BREA.0000019963.67754.93

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  14 in total

1.  Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells.

Authors:  Ines Barone; Stefania Catalano; Luca Gelsomino; Stefania Marsico; Cinzia Giordano; Salvatore Panza; Daniela Bonofiglio; Gianluca Bossi; Kyle R Covington; Suzanne A W Fuqua; Sebastiano Andò
Journal:  Cancer Res       Date:  2012-01-26       Impact factor: 12.701

2.  Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice.

Authors:  M H Herynk; M T Lewis; T A Hopp; D Medina; A Corona-Rodriguez; Y Cui; A R Beyer; S A W Fuqua
Journal:  Oncogene       Date:  2009-06-29       Impact factor: 9.867

3.  Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells.

Authors:  Yukun Cui; Airu Niu; Richard Pestell; Rakesh Kumar; Edward M Curran; Yunde Liu; Suzanne A W Fuqua
Journal:  Mol Endocrinol       Date:  2006-04-27

Review 4.  Estrogen receptor mutations and changes in downstream gene expression and signaling.

Authors:  Ines Barone; Lauren Brusco; Suzanne A W Fuqua
Journal:  Clin Cancer Res       Date:  2010-04-28       Impact factor: 12.531

5.  Absence of the K303R estrogen receptor α mutation in breast cancer patients exhibiting different responses to aromatase inhibitor anastrozole neoadjuvant treatment.

Authors:  Chiara Ghimenti; Maurizia Mello-Grand; Lea Regolo; Alberto Zambelli; Giovanna Chiorino
Journal:  Exp Ther Med       Date:  2010-09-17       Impact factor: 2.447

Review 6.  ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer.

Authors:  Rinath Jeselsohn; Gilles Buchwalter; Carmine De Angelis; Myles Brown; Rachel Schiff
Journal:  Nat Rev Clin Oncol       Date:  2015-06-30       Impact factor: 66.675

Review 7.  Epigenetics meets estrogen receptor: regulation of estrogen receptor by direct lysine methylation.

Authors:  Qun Zhou; Patrick G Shaw; Nancy E Davidson
Journal:  Endocr Relat Cancer       Date:  2009-02-10       Impact factor: 5.678

Review 8.  Emerging roles of lysine methylation on non-histone proteins.

Authors:  Xi Zhang; Yaling Huang; Xiaobing Shi
Journal:  Cell Mol Life Sci       Date:  2015-07-31       Impact factor: 9.261

9.  Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway.

Authors:  Ines Barone; Yukun Cui; Matthew H Herynk; Arnoldo Corona-Rodriguez; Cinzia Giordano; Jennifer Selever; Amanda Beyer; Sebastiano Andò; Suzanne A W Fuqua
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

10.  Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients.

Authors:  Peilu Wang; Amir Bahreini; Rekha Gyanchandani; Peter C Lucas; Ryan J Hartmaier; Rebecca J Watters; Amruth R Jonnalagadda; Humberto E Trejo Bittar; Aaron Berg; Ronald L Hamilton; Brenda F Kurland; Kurt R Weiss; Aju Mathew; Jose Pablo Leone; Nancy E Davidson; Marina N Nikiforova; Adam M Brufsky; Tadeu F Ambros; Andrew M Stern; Shannon L Puhalla; Adrian V Lee; Steffi Oesterreich
Journal:  Clin Cancer Res       Date:  2015-10-23       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.